Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX
Khan Najat had 62,701 Recursion Pharmaceuticals, Inc. shares withheld for tax (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Khan Najat (Director, CEO and President) had 62,701 Recursion Pharmaceuticals, Inc. shares withheld for tax at US$3.04 for US$191K, leaving 2,199,384 shares. Filed May 19, 2026 (Form 4).
- Withheld for tax
- 62,701 shares
- Price
- US$3.04
- Value
- US$191K
- Holding after
- 2,199,384 shares
- Trading plan
- No
- Role
- Director, CEO and President
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Class A Common Stock | Shares withheld for tax | 62,701 | US$3.04 | 2,199,384 | Direct |
Source
Related
- Recursion Pharmaceuticals, Inc.
- Khan Najat
- Recursion Pharmaceuticals, Inc. shareholders
- Form 4 · Khan Najat · Sep 10, 2026
- Form 4 · Khan Najat · Aug 18, 2026
- Form 4 · Khan Najat · Jun 5, 2026
- Form 4 · Borgeson Blake · Oct 7, 2026
- Form 4 · Hershberg Robert · Oct 7, 2026
- Form 4 · Dar Zavain · Oct 2, 2026
- Form 4 · Li Dean Y · Oct 2, 2026
- Form 4 · Taylor Ben R · Sep 16, 2026